Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$3,189 Mln
Revenue (TTM)
$2,372 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
35.9
P/B Ratio
2.7
Industry P/E
36.41
EV/EBITDA
14
Div. Yield
0 %
Debt to Equity
0.3
Book Value
$--
EPS
$3.4
Face value
--
Shares outstanding
32,819,600
CFO
$1,384.04 Mln
EBITDA
$1,909.80 Mln
Net Profit
$825.04 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Amedisys (AMED)
| 7.2 | 3.9 | 5.2 | 6.0 | -5.7 | -11.2 | 9.9 |
|
BSE Sensex*
| 4.6 | -0.6 | 10.9 | 6.3 | 16.7 | 19.5 | 11.9 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Amedisys (AMED)
| -4.5 | 13.8 | -48.4 | -44.8 | 75.7 | 42.5 | 121.2 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 | -9.7 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 | 5.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Amedisys (AMED)
|
97.3 | 3,188.8 | 2,371.7 | 114.4 | 6.7 | 10.1 | 35.9 | 2.7 |
| 552.4 | 8,063.1 | 2,489.0 | 308.7 | 16.3 | 25.5 | 26.8 | 6.9 | |
| 103.0 | 5,395.4 | 895.6 | 95.2 | 9.8 | 33.4 | 57.4 | 16.9 | |
| 137.8 | 10,380.5 | 12,968.5 | 859.6 | 15.0 | -- | 13.5 | 21.6 | |
| 120.5 | 12,188.4 | 5,512.6 | 494.7 | 17.0 | 16.3 | 24.9 | 5.6 | |
| 31.8 | 5,218.6 | 5,185.1 | 213.8 | 6.6 | 15.4 | 25.3 | 3.8 | |
| 57.4 | 4,245.2 | 1,869.4 | -14.6 | 4.8 | -5.7 | -- | 4.6 | |
| 11.3 | 3,335.3 | 1,106.8 | 24.8 | 21.6 | 5.6 | 127 | 7.8 | |
| 152.6 | 8,695.2 | 4,423.4 | 309.4 | 9.2 | 16.8 | 28.6 | 4.5 | |
| 170.4 | 11,190.7 | 16,084.1 | 1,196.9 | 10.9 | 17.4 | 9.6 | 1.6 |
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of... individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana. Read more
Executive VP, COO, CFO & Principal Financial Officer
Mr. Scott G. Ginn
Executive VP, COO, CFO & Principal Financial Officer
Mr. Scott G. Ginn
Headquarters
Baton Rouge, LA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Amedisys Inc (AMED) stood at $ 2,677 Mln as on 31-Mar-25
The share price of Amedisys Inc (AMED) is $97.34 (NASDAQ) as of 16-Jun-2025 16:00 EDT. Amedisys Inc (AMED) has given a return of -5.71% in the last 3 years.
Amedisys Inc (AMED) has a market capitalisation of $ 3,189 Mln as on 13-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Amedisys Inc (AMED) is 2.66 times as on 13-Jun-2025, a 2% premium to its peers’ median range of 2.62 times.
The P/E ratio of Amedisys Inc (AMED) is 35.85 times as on 13-Jun-2025, a 2% discount to its peers’ median range of 36.41 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Amedisys Inc (AMED) and enter the required number of quantities and click on buy to purchase the shares of Amedisys Inc (AMED).
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care, and palliative care to patients in their homes. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.
The CEO & director of Mr. Scott G. Ginn. is Amedisys Inc (AMED), and CFO & Sr. VP is Mr. Scott G. Ginn.
There is no promoter pledging in Amedisys Inc (AMED).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
1,204
|
|
|
1,110
|
|
|
1,044
|
|
|
859
|
|
|
803
|
|
|
555
|
|
|
519
|
|
|
434
|
|
|
342
|
| Amedisys Inc (AMED) | Ratios |
|---|---|
|
Return on equity(%)
|
10.13
|
|
Operating margin(%)
|
6.66
|
|
Net Margin(%)
|
4.82
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Amedisys Inc (AMED) was $0 Mln.
$0.18
(
